SPARC and invasive breast carcinoma: While normal mammary tissue has undetectable or lightly detectable amounts of SPARC, and benign breast lesions are weakly positive, 75% of both in situ and invasive breast carcinomas are strongly positive for SPARC in stromal cells (CD-34-negative, α-SMA-positive) [7,8].